Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos

Sci Adv. 2020 May 13;6(20):eaaz0298. doi: 10.1126/sciadv.aaz0298. eCollection 2020 May.

Abstract

It has not been possible to generate naïve human pluripotent stem cells (hPSCs) that substantially contribute to mouse embryos. We found that a brief inhibition of mTOR with Torin1 converted hPSCs from primed to naïve pluripotency. The naïve hPSCs were maintained in the same condition as mouse embryonic stem cells and exhibited high clonogenicity, rapid proliferation, mitochondrial respiration, X chromosome reactivation, DNA hypomethylation, and transcriptomes sharing similarities to those of human blastocysts. When transferred to mouse blastocysts, naïve hPSCs generated 0.1 to 4% human cells, of all three germ layers, including large amounts of enucleated red blood cells, suggesting a marked acceleration of hPSC development in mouse embryos. Torin1 induced nuclear translocation of TFE3; TFE3 with mutated nuclear localization signal blocked the primed-to-naïve conversion. The generation of chimera-competent naïve hPSCs unifies some common features of naïve pluripotency in mammals and may enable applications such as human organ generation in animals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Cell Differentiation
  • Chimera
  • Humans
  • Mammals
  • Mice
  • Pluripotent Stem Cells*
  • TOR Serine-Threonine Kinases

Substances

  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • MTOR protein, human
  • TOR Serine-Threonine Kinases